Synthetic amorphous calcium phosphates (ACPs): preparation, structure, properties, and biomedical applications

Amorphous calcium phosphates (ACPs) represent a metastable amorphous state of other calcium orthophosphates (abbreviated as CaPO₄) possessing variable compositional but rather identical glass-like physical properties, in which there are neither translational nor orientational long-range orders of the atomic positions. In nature, ACPs of a biological origin are found in the calcified tissues of mammals, some parts of primitive organisms, as well as in the mammalian milk. Manmade ACPs can be synthesized in a laboratory by various methods including wet-chemical precipitation, in which they are the first solid phases, precipitated after a rapid mixing of aqueous solutions containing dissolved ions of Ca²⁺ and PO₄^3- in sufficient amounts. Due to the amorphous nature, all types of synthetic ACPs appear to be thermodynamically unstable and, unless stored in dry conditions or doped by stabilizers, they tend to transform spontaneously to crystalline CaPO₄, mainly to ones with an apatitic structure. This intrinsic metastability of the ACPs is of a great biological relevance. In particular, the initiating role that metastable ACPs play in matrix vesicle biomineralization raises their importance from a mere laboratory curiosity to that of a reasonable key intermediate in skeletal calcifications. In addition, synthetic ACPs appear to be very promising biomaterials both for manufacturing artificial bone grafts and for dental applications. In this review, the current knowledge on the occurrence, structural design, chemical composition, preparation, properties, and biomedical applications of the synthetic ACPs have been summarized.

Hydroxylapatite nanoparticles: fabrication methods and medical applications

Hydroxylapatite (or hydroxyapatite, HAp) exhibits excellent biocompatibility with various kinds of cells and tissues, making it an ideal candidate for tissue engineering, orthopedic and dental applications. Nanosized materials offer improved performances compared with conventional materials due to their large surface-to-volume ratios. This review summarizes existing knowledge and recent progress in fabrication methods of nanosized (or nanostructured) HAp particles, as well as their recent applications in medical and dental fields. In section 1, we provide a brief overview of HAp and nanoparticles. In section 2, fabrication methods of HAp nanoparticles are described based on the particle formation mechanisms. Recent applications of HAp nanoparticles are summarized in section 3. The future perspectives in this active research area are given in section 4.

Amorphous Calcium Phosphates

Amorphous calcium phosphates (ACPs) represent a unique class of biomedically relevant calcium orthophosphate salts, in which there are neither translational nor orientational long-range orders of the atomic positions. Nevertheless, the constancy in their chemical composition over a relatively wide range of preparation conditions suggests the presence of a well-defined local structural unit, presumably, with the structure of Ca9(PO4)6 – so-called Posner’s cluster. ACPs have variable chemical but rather identical glass-like physicochemical properties. Furthermore, all ACPs are thermodynamically unstable compounds and, unless stored in dry conditions or doped by stabilizers, spontaneously they tend to transform to crystalline calcium orthophosphates. Although some order within general disorder is the most distinguishing feature of ACPs, the solution instability of ACPs and their easy transformation to crystalline phases might be of a great biological relevance. Namely, the initiating role ACPs play in matrix vesicle biomineralization raises the importance of this phase from a mere laboratory curiosity to that of a key intermediate in skeletal calcification. Furthermore, ACPs are very promising candidates to manufacture artificial bone grafts.

Structural and compositional features of amorphous calcium phosphate at the early stage of precipitation

Precipitates formed at an early stage (during the first 6 h) of the hydroxyapatite crystallization of a solution were studied. A nitrous synthesis was used (0.583M (NH(4))(2)HPO(4) and 0.35 M Ca(NO(3))(2).4H(2)O solutions at pH 11-12, 21 degrees C, fast mixing, lyophilization of aliquots). Although XRD patterns indicated an amorphous calcium phosphate (ACP), IR spectra revealed apatite nanocrystals in the precipitates. Some amount of free calcium was found in the mother solution by mass spectrometrical analysis of the aliquots. This amount considerably decreased as the synthesis proceeded, however, the decrease had a slight effect on the crystallinity of the precipitates. A new suggestion on the nature of delayed crystallization (under conditions as those in the present study) was proposed. The free calcium adsorbed by the nanoparticles from the solution formed a shell around a particle because the calcium diffusion into the bulk was poor at the low synthesis temperature. As such, the encapsulation delayed the crystallization of the nanoparticles. Evidence for this suggestion was given. New possibilities were proposed for preparation of bioactive materials of desired composition based on the structural and compositional peculiarities of the X-ray diffraction-amorphous calcium phosphates.